IATA (International Air Transport Association) has joined forces with a medical services company to incorporate testing solutions into the IATA Travel Pass.
Through the partnership with SYNLAB, passengers using IATA Travel Pass will be able to locate authorised laboratories at departure locations to get tested as required by border and health authorities.
After testing, SYNLAB will provide passengers with their certified test results through the IATA Travel Pass. The app checks the result against the IATA Travel Pass registry of national entry requirements to produce an “OK to Travel” status. Through the app passengers can share their status and the digital test certificates with authorities and airlines to facilitate travel.
With results sent directly by SYNLAB to the passenger's app, data is kept secure. The process also prevents potential forgery of test results.
SYNLAB has a network of more than 450 testing laboratories and more than 1,600 sample collection points across 36 countries.
Willie Walsh, IATA’s Director General, stated: “Verified Covid-19 testing is critical to restore the freedom to travel for people who are not vaccinated. IATA Travel Pass aims to make it as simple as possible for travellers to locate certified labs and securely receive the test results that governments require for entry. Adding SYNLAB’s extensive lab network will help travellers more easily ensure that they meet their Covid-19 travel requirements.”
Mathieu Floreani, CEO of SYNLAB, added: “At a time when people around the world are resuming air travel and different variants of the virus are spreading, testing remains crucial. Testing is a central pillar in monitoring and controlling the pandemic to prevent the spread of the virus."